Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nordic Specialty Pharma Development AB
AB
Active
Org 5591041073
Retail sale of pharmaceutical products
· NACE 4773
Est. 2017
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Nordic Specialty Pharma Development AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MM
Miriam Mikha
Deputy Board Member
2024
FM
Fadi Mikha
Board of Directors
2022
Former (2)
KH
Karlos Hanna
Deputy Board Member
2022 – 2022
WM
Wael Mikha
Deputy Board Member
2022 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Nordic Specialty Pharma Development AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network